The estimated Net Worth of Martin Meglasson is at least $1.97 Milione dollars as of 20 May 2015. Martin Meglasson owns over 712 units of Ligand Pharmaceuticals stock worth over $1,968,813 and over the last 20 years Martin sold LGND stock worth over $0.
Martin has made over 2 trades of the Ligand Pharmaceuticals stock since 2015, according to the Form 4 filled with the SEC. Most recently Martin bought 712 units of LGND stock worth $5,981 on 20 May 2015.
The largest trade Martin's ever made was buying 12,000 units of Ligand Pharmaceuticals stock on 19 February 2015 worth over $144,000. On average, Martin trades about 748 units every 5 days since 2004. As of 20 May 2015 Martin still owns at least 19,098 units of Ligand Pharmaceuticals stock.
You can see the complete history of Martin Meglasson stock trades at the bottom of the page.
Martin's mailing address filed with the SEC is 10275 SCIENCE CENTER DRIVE, , SAN DIEGO, CA, 9121.
Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over $205,340,014 worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth $27,601,439 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... e Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of $2,239,733. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth $50,090.
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: